The Division of Immunology at Children’s National Medical Center is a national leader in treating and managing primary immunodeficiencies in infants, children, adolescents, and young adults, including:
Agammaglobulinemia
Ataxia-telangiectasia (AT)
Autoimmune lymphoproliferative syndrome (ALPS)
Chronic granulomatous disease (CGD)
Common variable immunodeficiency (CVID)
DiGeorge syndrome
Hemophagocytic lymphohistiocytosis (HLH)
Hypogammaglobulinemia
Leukocyte adhesion deficiency (LAD)
Severe combined immunodeficiency (SCID)
Wiskott-Aldrich syndrome (WAS)
X-linked agammaglobulinemia (XLA)
By providing individual treatment plans, tailored to each patient’s specific needs, the Immunology team helps each patient lead a fuller life.
Children’s patients have access to cutting-edge experimental therapeutics through several clinical trials for primary immunodeficiency diseases. The Immunology team also provides services and treatments, such as:
Diagnostic evaluation.
Immune function testing.
Ongoing management of chronic immune disorders.
Intravenous immunoglobulin (IVIG) treatment in the hospital’s infusion center.